Infectious Disease

Top Story

Preemptive DAA therapy viable for HCV-positive liver transplantation

October 22, 2017

WASHINGTON — Results of a virtual trial showed that transplantation with hepatitis C-positive livers with preemptive direct-active antiviral therapy may be a viable option for improving patient survival on the liver transplant waitlist, according to an expert at The Liver Meeting 2017.

“The fact is that donor liver availability continues to be limiting factor in increasing the number of liver transplants. Therefore, it becomes very important that we utilize all organs for a maximum potential,” Jagpreet Chhatwal, PhD, from the Massachusetts General Hospital and Harvard Medical School, said in his presentation. “However, under current guidelines, hep C-positive livers are not transplanted into hep C-negative recipients because of adverse post-transplant outcomes previously demonstrated in the interferon-based therapy [era]. But several things have changed in the last few years that prompt us to revisit this question.”

Meeting News

Sarasar with Norvir effectively delays HDV progression, may clear virus

October 22, 2017
Combination therapy with Sarasar and Norvir in patients with hepatitis D effectively blocked hepatitis D virus production, regardless of Sarasar dose, according to a…
In the Journals Plus

Influenza pandemics more likely to emerge in spring, summer

October 22, 2017
A recent modeling study showed that influenza pandemics are more likely to occur in spring and summer months than during the height of a seasonal influenza epidemic…
Meeting News

Tenofovir exalidex safe, well-tolerated in early HBV trial

October 21, 2017
Tenofovir exalidex, a novel prodrug of tenofovir, appeared safe and well-tolerated in patients with hepatitis B, according to a presentation at The Liver Meeting 2017…

Gilead awards $7.5 million to support HIV cure initiatives

October 21, 2017
In a second round of funding, Gilead Sciences’ HIV cure grants program will provide $7.5 million to five additional research initiatives focused on curing HIV…
More Headlines »
CME CE CNE CPE CPE

HIV/AIDS 1 Hour Update For Florida Health Professionals

No commercial support for this activity.

This is a 1 hour activity designed for home study by healthcare clinicians. Specifically, it meets the 1 hour HIV/AIDS…
More »

Gilead awards $7.5 million to support HIV cure initiatives

October 21, 2017
In a second round of funding, Gilead Sciences’ HIV cure grants program will provide $7.5 million to five…
More »
Resource Centers
IDWeek

IDWeek

Video

VIDEO: Influenza vaccination among HCWs a ‘patient safety issue’

October 5, 2017
More »
Advertisement
Advertisement